Renal Outcomes With Tenofovir Alafenamide in Liver Transplant Recipients

被引：3
|
作者：
Liu, Joanne K. [1 ]
Vutien, Philip [2 ]
Huang, Daniel Q. [3 ]
Ishigami, Masatoshi [4 ]
Landis, Charles S. [2 ]
Nguyen, Mindie H. [5 ,6 ]
机构：
[1] Univ Washington, Seattle, WA USA
[2] Hepatol Univ Washington, Div Gastroenterol, Seattle, WA USA
[3] Natl Univ Singapore, Natl Univ Hosp, Yong Loo Lin Sch Med, Div Gastroenterol & Hepatol,Dept Med, Singapore, Singapore
[4] Hepatol Nagoya Univ, Grad Sch Med, Div Gastroenterol, Nagoya, Japan
[5] Stanford Univ, Med Ctr, Div Gastroenterol & Hepatol, Palo Alto, CA USA
[6] Stanford Univ, Med Ctr, 780 Welch Rd, Palo Alto, CA 94304 USA
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 21卷 / 02期
关键词：
D O I：
10.1016/j.cgh.2022.01.035
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：7
相关论文
共 50 条
  • [1] RENAL OUTCOMES IN POST-LIVER TRANSPLANT RECIPIENTS TREATED WITH TENOFOVIR ALAFENAMIDE COMPARED WITH TENOFOVIR DISOPROXIL FUMARATE AND ENTECAVIR
    Liu, Joanne
    Vutien, Philip
    Huang, Daniel
    Ishigami, Masatoshi
    Daniel, Peter Chen Yang Nikhil
    Ito, Takanori
    Dang, Hansen
    Maeda, Mayumi
    Leong, Jennifer
    Landis, Charles
    Nguyen, Mindie H.
    HEPATOLOGY, 2021, 74 : 492A - 493A
  • [2] Potential Benefits of Switching Liver Transplant Recipients to Tenofovir Alafenamide Prophylaxis
    Sripongpun, Pimsiri
    Mannalithara, Ajitha
    Kwo, Paul Y.
    Kim, W. Ray
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (03) : 747 - 749
  • [3] Safety and efficacy of tenofovir alafenamide in liver transplant recipients: A single center experience
    Rashidi-Alavijeh, Jassin
    Straub, Katja
    Achterfeld, Anne
    Wedemeyer, Heiner
    Willuweit, Katharina
    Herzer, Kerstin
    TRANSPLANT INFECTIOUS DISEASE, 2021, 23 (03)
  • [4] POST TRANSPLANT RENAL OUTCOMES AMONG LIVER TRANSPLANT RECIPIENTS WITH PRESERVED RENAL FUNCTION
    Sharma, Pratima
    Tischer, Sarah
    Kwon, Hellan
    Sonnenday, Christopher
    Park, Jeong
    GASTROENTEROLOGY, 2020, 158 (06) : S1339 - S1339
  • [5] Safety of tenofovir alafenamide in renal impairment
    Pozniak, A.
    Arribas, J.
    Gupta, S.
    Post, F.
    Avihingsanon, A.
    Crofoot, G.
    Lichtenstein, K.
    Ramgopa, M.
    Chetchotisakd, P.
    Benn, P.
    Fordyce, M. W.
    HIV MEDICINE, 2015, 16 : 33 - 33
  • [6] Effects of Timing of Everolimus Transition on Renal Outcomes in Liver Transplant Recipients
    Leick, M.
    Belleau, H.
    McCashland, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 359 - 359
  • [7] Analysis of Renal Outcomes for Simultaneous Liver Kidney Transplant (SLKT) and Liver Transplant Alone (LTA) Recipients
    Lunsford, K. E.
    Ma, M.
    Vageli, P. A.
    Brennan, T. V.
    Feng, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 197 - 198
  • [8] A balance of risks: an audit of lipid and renal outcomes in patients prescribed tenofovir alafenamide
    Wu, M-S
    Brawley, D.
    HIV MEDICINE, 2019, 20 : 34 - 35
  • [9] Pregnancy outcomes in renal transplant recipients
    Puthenveettil, Nitu
    Mohan, Anish
    Rahman, Sajan
    Paul, Jerry
    INDIAN JOURNAL OF ANAESTHESIA, 2021, 65 (09) : 695 - 699
  • [10] Renal biopsy in liver transplant recipients
    O'Riordan, Aisling
    Dutt, Neelanjana
    Cairns, Hugh
    Rela, Mohamed
    O'Grady, John G.
    Heaton, Nigel
    Hendry, Bruce M.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (07) : 2276 - 2282
12345